Gentian Diagnostics ASA (OSL:GENT)
Norway
· Delayed Price · Currency is NOK 37.70
-1.30 (-3.33%)
Mar 9, 2026, 4:25 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 601.47 million as of March 9, 2026. Its market cap has decreased by -20.41% in one year.
Market Cap
601.47M
Enterprise Value
514.98M
Revenue
176.50M
Ranking
n/a
PE Ratio
45.37
Stock Price
37.70
Market Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 601.47M, an increase of 107.68%. That is a compound annual growth rate of 8.23%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.95B |
| Nordhealth AS | 2.31B |
| Photocure ASA | 1.86B |
| Thor Medical ASA | 1.54B |
| Nykode Therapeutics AS | 1.03B |
| Vistin Pharma ASA | 957.84M |
| Omda AS | 840.81M |
| Lytix Biopharma AS | 730.55M |